| Date Filed | Type | Description |
| 07/13/2023 |
4
| Blumenkranz Mark S. (Director) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Disposed/sold 32,088 shares
@ $0
Disposed/sold 5,000 restricted stock units
@ $0
Disposed/sold 7,500 restricted stock units
@ $0
Disposed/sold 31,000 options to buy
@ $4.48, valued at
$138.9k
Disposed/sold 15,500 options to buy
@ $6.82, valued at
$105.7k
Disposed/sold 23,186 options to buy
@ $9.94, valued at
$230.5k
|
|
| 06/02/2023 |
4
| Blumenkranz Mark S. (Director) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Disposed of 3 shares
@ $0
Granted 2,013 shares
@ $0
Granted 1,640 shares
@ $0
Disposed of 68 shares
@ $0
Granted 65,634 shares
@ $0
Disposed of 2 shares
@ $0
Granted 497 shares
@ $0
Disposed/sold 840 options to buy
@ $0
Disposed/sold 800 options to buy
@ $0 |
|
| 05/19/2023 |
4
| Blumenkranz Mark S. (Director) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Granted 7,500 restricted stock units
@ $0 |
|
| 05/15/2023 |
4
| Blumenkranz Mark S. (Director) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Exercised 14,588 restricted stock units
@ $0 |
|
| 02/24/2023 |
4
| Blumenkranz Mark S. (Director) has filed a Form 4 on 1Life Healthcare Inc|
Txns:
| Disposed/sold 4,534 shares
@ $18, valued at
$81.6k
Disposed/sold 10,381 options to buy
@ $11.56, valued at
$120k
Disposed/sold 5,294 options to buy
@ $29, valued at
$153.5k
Disposed/sold 20,728 restricted stock units
@ $0 |
|
| 07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2021 |
SC 13D
| Blumenkranz Mark S. reports a 7.3% stake in Kala Pharmaceuticals, Inc. |
| 11/17/2021 |
4
| Blumenkranz Mark S. (Director) has filed a Form 4 on Kala Pharmaceuticals, Inc.|
Txns:
| Granted 157,765 shares
@ $0
Granted 5,144,390 shares
@ $0
Granted 38,965 shares
@ $0
Granted 42,000 options to buy
@ $2.1, valued at
$88.2k
|
|
| 11/17/2021 |
3
| Blumenkranz Mark S. (Director) has filed a Form 3 on Kala Pharmaceuticals, Inc. |
| 07/19/2021 |
4
| Blumenkranz Mark S. (Director) has filed a Form 4 on IVERIC bio, Inc.|
Txns:
| Exercised 5,000 restricted stock units
@ $0 |
|
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/18/2020 |
4
| Blumenkranz Mark S. (Director) has filed a Form 4 on 1Life Healthcare Inc|
Txns:
| Granted 5,294 options to buy
@ $29, valued at
$153.5k
|
|
| 01/30/2020 |
3
| Blumenkranz Mark S. (Director) has filed a Form 3 on 1Life Healthcare Inc |